Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/15845647

Download in:

View as

General Info

PMID
15845647